These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22664831)
1. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Hamada A; Yamakado K; Nakatsuka A; Uraki J; Kashima M; Takaki H; Yamanaka T; Inoue Y; Kusunoki M; Takeda K Jpn J Radiol; 2012 Aug; 30(7):567-74. PubMed ID: 22664831 [TBL] [Abstract][Full Text] [Related]
2. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation. Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637 [TBL] [Abstract][Full Text] [Related]
4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival. Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677 [TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832 [TBL] [Abstract][Full Text] [Related]
11. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma. Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394 [TBL] [Abstract][Full Text] [Related]
14. [Radiofrequency ablation of colorectal liver metastases]. Frich L; Brabrand K; Aaløkken TM; Edwin B; Gladhaug IP Tidsskr Nor Laegeforen; 2008 Jan; 128(1):57-60. PubMed ID: 18183060 [TBL] [Abstract][Full Text] [Related]
15. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. Berber E; Pelley R; Siperstein AE J Clin Oncol; 2005 Mar; 23(7):1358-64. PubMed ID: 15684312 [TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome. Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Hur H; Ko YT; Min BS; Kim KS; Choi JS; Sohn SK; Cho CH; Ko HK; Lee JT; Kim NK Am J Surg; 2009 Jun; 197(6):728-36. PubMed ID: 18789428 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy. Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors. Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558 [TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]